Spectracell Laboratories Inc

Specialties

SpectraCell Laboratories, Inc. has become the nation’s leader in nutritional testing by utilizing the most advanced technology, providing the highest quality service to our physician clients nationwide, and understanding the ultimate responsibility is patient care. A CLIA accredited laboratory, SpectraCell has expanded its specialized offerings to include the most advanced tests for assessment of cardiovascular risk. Through its dedication to research and development, SpectraCell also provides innovative diagnostic analyses in the emerging field of anti-​aging medicine.

History

Established in 1993.

SpectraCell Laboratories, Inc., is a specialized clinical testing laboratory company. We were established in 1993 to commercialize a patented, groundbreaking technology for micronutrient testing.

The technology was developed at the University of Texas, by the Clayton Foundation for Research, as a diagnostic blood test for helping clinicians assess the intracellular function of essential micronutrients.

Since acquiring the rights to the technology, SpectraCell has become the premier provider of tests for identifying subclinical nutritional deficiencies. Our corporate headquarters recently expanded its state-​of-​the-​art facilities in Houston, TX to encompass 30,000 square feet of laboratory and administrative space. This expansion was undertaken in response to the growth in demand for nutritional and cardiovascular testing that you, our clients, have generated, for which we are sincerely appreciative.

Meet the Business Owner

William S.

Business Owner

Chief Executive Officer — From 1974 to 1980, Mr. Stanberry was President of Hycel, Inc. (AMEX), a laboratory instrument and diagnostics Company where he had previously served as Chief Financial Officer and House Counsel. He then founded and was Chief Executive Officer of Surgicare Corporation (NASDAQ), an operator of outpatient surgical centers, from 1980 to 1984, and was Chairman of a successor company, Medical Care International, Inc. (NYSE), from 1984 to 1985. Mr. Stanberry subsequently founded and served as Chief Executive Officer from 1986 to 1991 of OmniMed Corporation, a diversified, privately-​owned medical investment and holding company. Mr. Stanberry holds a B.A. from Yale University and a J. D. from The University of Texas School of Law.